WO2020161378A3 - Método para diagnosticar o pronosticar el desarrollo de cáncer de próstata en un individuo - Google Patents

Método para diagnosticar o pronosticar el desarrollo de cáncer de próstata en un individuo Download PDF

Info

Publication number
WO2020161378A3
WO2020161378A3 PCT/ES2020/070086 ES2020070086W WO2020161378A3 WO 2020161378 A3 WO2020161378 A3 WO 2020161378A3 ES 2020070086 W ES2020070086 W ES 2020070086W WO 2020161378 A3 WO2020161378 A3 WO 2020161378A3
Authority
WO
WIPO (PCT)
Prior art keywords
prognosing
diagnosing
development
individual
prostate cancer
Prior art date
Application number
PCT/ES2020/070086
Other languages
English (en)
French (fr)
Other versions
WO2020161378A2 (es
Inventor
Raúl Miguel LUQUE HUERTAS
Manuel David Gahete Ortiz
Justo P. CASTAÑO FUENTES
Juan Manuel JIMÉNEZ VACAS
André MORÁIS SARMENTO BORGES
Fernando LÓPEZ LÓPEZ
María José REQUENA TAPIA
Enrique GÓMEZ GÓMEZ
Julia CARRASCO VALIENTE
Original Assignee
Universidad de Córdoba
Servicio Andaluz De Salud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Córdoba, Servicio Andaluz De Salud filed Critical Universidad de Córdoba
Publication of WO2020161378A2 publication Critical patent/WO2020161378A2/es
Publication of WO2020161378A3 publication Critical patent/WO2020161378A3/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Biomarcadores, método, kit de diagnóstico y usos para diagnosticar, predecir o pronosticar el desarrollo de cáncer de próstata (CaP) en un individuo.
PCT/ES2020/070086 2019-02-08 2020-02-08 Método para diagnosticar o pronosticar el desarrollo de cáncer de próstata en un individuo WO2020161378A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201930104 2019-02-08
ESP201930104 2019-02-08

Publications (2)

Publication Number Publication Date
WO2020161378A2 WO2020161378A2 (es) 2020-08-13
WO2020161378A3 true WO2020161378A3 (es) 2020-12-10

Family

ID=71947058

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2020/070086 WO2020161378A2 (es) 2019-02-08 2020-02-08 Método para diagnosticar o pronosticar el desarrollo de cáncer de próstata en un individuo

Country Status (1)

Country Link
WO (1) WO2020161378A2 (es)

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "GeneChip® Human Genome Arrays", AFFYMETRIX - DATA SHEET, 1 January 2004 (2004-01-01), XP002384937, Retrieved from the Internet <URL:https://www.affymetrix.com/support/technical/datasheets/human_datasheet.pdf> [retrieved on 20200617] *
ANONYMOUS: "Information for Gene Symbol snRNP200", HUMAN GENOME U133 PLUS 2.0 ARRAY, 1 January 2004 (2004-01-01), Retrieved from the Internet <URL:https://genecards.weizmann.ac.ll/egi-bin/geneannol/GAsearch.pl?array=HG-U95&array=integrated&.submit=Suhmit+QueryU133Plus2&keywordtype=probesethst&keyword=200058yat&target=integrated&.submit=Submit+query> [retrieved on 20200617] *
GERHAUSER CLARISSA ET AL.: "Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories", CANCER CELL CELL PRESS, vol. 34, no. 6, 2018, pages 996, XP085555153, ISSN: 1535-6108, DOI: 10.1016/j.ccell. 2018.10.01 6 *
JIMENEZ-VACAS J M ET AL.: "Spliceosome components and splicing factors as novel therapeutic targets for prostate cancer", EUROPEAN UROLOGY, vol. 18, no. 1, March 2019 (2019-03-01), pages e71, XP055763978, ISSN: 1569-9056, DOI: 10.1016/S1569-9056(19)30054-5 *
JIMENEZ-VACAS JUAN M ET AL.: "Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer", EBIOMEDICINE, vol. 51, January 2020 (2020-01-01), pages 102547, XP055763975, ISSN: 2352-3964, DOI: 10.1016/j.ebiom. 2019.11.00 8 pubmed:31902674 *
KURUMA HIDETOSHI ET AL.: "Staphylococcal Nuclease Domain-Containing Protein 1 as a Potential Tissue Marker for Prostate Cancer", AMERICAN JOURNAL OF PATHOLOGY, vol. 174, no. 6, 1 April 2009 (2009-04-01), pages 2044 - 2050, XP027041927, ISSN: 0002-9440, DOI: 10.2353/ajpath.2009.080776 *
SATO NAOKI ET AL.: "Inhibition of SNWI association with spliceosomal proteins promotes apoptosis in breast cancer cells", CANCER MEDICINE, vol. 4, no. 2, February 2015 (2015-02-01), pages 268 - 277, XP055763984, ISSN: 2045-7634, DOI: 10.1002/cam4.366 pubmed:25450007 *
TAKAYAMA KEN-ICHI ET AL.: "Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA UNITED STATES, vol. 114, no. 39, 26 September 2017 (2017-09-26), pages 10461 - 10466, XP055763981, ISSN: 1091-6490, DOI: 10.1073/pnas.1706076114 *

Also Published As

Publication number Publication date
WO2020161378A2 (es) 2020-08-13

Similar Documents

Publication Publication Date Title
WO2019213282A8 (en) Biomarkers for evaluating car-t cells to predict clinical outcome
CA2602088C (en) Biomarkers for ovarian cancer and endometrial cancer
WO2018187496A8 (en) PLASMA PROTEIN PROFILING FOR THE EARLY PROGNOSIS OF LUNG CANCER
EP4242329A3 (en) Use of markers including filamin a in the diagnosis and treatment of prostate cancer
WO2007035690A3 (en) Methods for diagnosing pancreatic cancer
BRPI0720371B8 (pt) métodos para diagnóstico ou monitoramento da progressão de câncer de próstata em um indivíduo e uso in vitro de pelo menos um homeodomínio contendo o fator de transcrição como um biomarcador para câncer de próstata
WO2008008500A3 (en) Methods for making cancer prognoses based on the subcellular localization of biomarkers
MX341517B (es) Biomarcadores de cancer pancreatico y usos de los mismos.
EP4219765A3 (en) Prostate cancer prognosis using biomarkers
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
WO2008061104A3 (en) Methods and kits for detecting prostate cancer biomarkers
SG165370A1 (en) Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites
MX2013000502A (es) Metodos y kits para el diagnostico de cancer de prostata.
WO2013057581A8 (en) Composite biomarker for non-invasive screening, diagnosis and prognosis of colorectal cancer
WO2017050939A3 (en) Method and array for diagnosing pancreatic cancer in an individual
WO2008097491A3 (en) Biomarkers of ionizing radiation response
WO2015095862A3 (en) Microrna biomarkers for ovarian cancer
WO2019055661A8 (en) Preeclampsia biomarkers and related systems and methods
GB201222576D0 (en) Method for diagnosing lung cancer
WO2022174234A3 (en) Biomarkers for cancer treatment
WO2007075672A3 (en) Prognostic cancer markers
MY195697A (en) Method of Prognosing and Predicting Breast Cancer Recurrence, Markers Employed Therein and Kit Thereof
GB2552271A (en) A method for diagnosing lung cancer
AU2010209763A8 (en) Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
WO2020161378A3 (es) Método para diagnosticar o pronosticar el desarrollo de cáncer de próstata en un individuo

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20751915

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20751915

Country of ref document: EP

Kind code of ref document: A2